| Pharmaceutical active ingredients: |
| Chloroprocaine Hydrochloride |
| Available forms, composition and doses of Ivracain: |
| Injectable; Injection; Chloroprocaine Hydrochloride 5 mg / ml |
| Ivracain medical category: |
| Human:Local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N01BA04 - Chloroprocaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sintetica |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Halestyn | Chloroprocaine | Unidentified Pharmaceutical Company |
| Piocaine | Chloroprocaine | Unidentified Pharmaceutical Company |
| Chloroprocain | Chloroprocaine Hydrochloride | Sintetica |
| Chloroprocaine | Chloroprocaine Hydrochloride | Bedford Laboratories |
| Chloroprocaine | Chloroprocaine Hydrochloride | Hospira |
| Nesacain | Chloroprocaine Hydrochloride | AstraZeneca |
| Nesacaine | Chloroprocaine Hydrochloride | AstraZeneca; APP Pharmaceuticals |
| Nesacaine CE | Chloroprocaine Hydrochloride | AstraZeneca |
| Nesacaine-MPF | Chloroprocaine Hydrochloride | AstraZeneca; APP Pharmaceuticals |
| Nesacain-MPF | Chloroprocaine Hydrochloride | AstraZeneca |